Home › Colon Cancer › Arizona › Tucson
Colon Cancer clinical trials in Tucson, AZ
4 studies for Colon Cancer are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecruitingPhase 3
- The University of Arizona Cancer Center, Tucson
- Roche Tissue Diagnostics, Companion Diagnostics, Tucson
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- University of Arizona Cancer Center - Prevention Research Clinic, Tucson
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RecruitingPhase 3
- GSK Investigational Site, Tucson
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Nashville, TN16 studies
- Los Angeles, CA16 studies
- Arlington, VA15 studies
- St. Louis, MO15 studies
- Chicago, IL14 studies
- Baldwin Park, CA14 studies
- San Antonio, TX14 studies
- Tampa, FL13 studies
- Baltimore, MD13 studies
Other studies in Tucson
- Breast Cancer20 studies
- Non-Small Cell Lung Cancer17 studies
- Obesity17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Steatotic Liver Disease10 studies
- Heart Failure10 studies
- High Blood Pressure10 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.